Robert J Ferguson Raine Riggs Tim Ahles and Andrew J Saykin

Dysfunction in memory and attention associated with cancer treatment has gained increased attention over the past two decades. In 1999 the President's Cancer Panel1 and the National Coalition for Cancer Survivorship2 formally recognized the problem as a quality of life matter that deserved higher priority in clinical research. With nearly 1 million chemotherapy recipients annually in the United States alone, the problem is widespread. Over this same time span, research has clearly documented...